cancer nausea associated fifty percent people affected may result cancer effect treatment chemotherapy radiation therapy medication opiates used pain relief people undergoing chemotherapy experience nausea vomiting nausea vomiting may also occur people receiving treatment often result disease involving gastrointestinal electrolyte imbalance result nausea vomiting may experienced unpleasant side effects cytotoxic may result patients delaying refusing strategies management therapy nausea vomiting depend underlying medical treatments conditions associated high risk nausea andor vomiting include chemotherapy radiotherapy malignant bowel anticipatory nausea vomiting may also nausea vomiting may lead medical conditions complications including dehydration electrolyte imbalance malnutrition decrease quality nausea may defined unpleasant sensation need may accompanied symptoms salivation feeling faint fast heart vomiting forceful ejection stomach contents although nausea vomiting closely related patients experience one symptom without may easier eliminate vomiting vomiting reflex also called emesis thought evolved many animal species protective mechanism ingested toxins humans vomiting response may preceded unpleasant sensation termed nausea nausea may also occur without vomiting central nervous system primary site number emetic stimuli input received processed efferent signals output generated response sent various effector organs tissues leading processes eventually end detection emetic stimuli central processing brain resulting response organs tissues lead nausea vomiting referred emetic pathway emetic arch medical conditions arise result cancer complication treatment known associated high risk nausea andor vomiting include malignant bowel obstruction mbo chemotherapyinduced nausea vomiting cinv anticipatory nausea vomiting anv radiotherapyinduced nausea vomiting rinvcitation needed malignant bowel obstruction mbo gastrointestinal tract common complication advanced cancer especially patients bowel gynaecological cancer include colorectal cancer ovarian cancer breast cancer three percent advanced cancers lead malignant bowel obstruction percent patients ovarian cancer experience least one episode malignant bowel mechanisms action may lead nausea mbo include mechanical compression gut motility disorders gastrointestinal secretion accumulation decreased gastrointestinal absorption bowel obstruction resulting nausea may also occur result anticancer therapy adhesion impaired gastric emptying result bowel obstruction may respond drugs alone surgical intervention sometimes means symptom constipating drugs used cancer therapy opioids may cause slowing peristalsis gut may lead functional bowel chemotherapyinduced nausea vomiting cinv one feared side effects associated significant deterioration quality cinv classified three risk factors predict occurrence severity cinv include sex age females younger people people high pretreatment expectation nausea higher risk people history high alcohol consumption lower personrelated variables chemotherapy dose rate route administration hydration status prior history cinv emesis pregnancy motion sickness tumour burden concomitant medication medical conditions also play role degree cinv experienced far important factor determines degree cinv emetogenic potential chemotherapeutic agents used chemotherapeutic agents classified four groups according degree emetogenicity high moderate low european society medical oncology esmo multinational association supportive care cancer mascc well american society clinical oncology asco recommend prophylaxis prevent acute vomiting nausea following chemotherapy high emetic risk drugs using threedrug regimen including receptor antagonist dexamethasone aprepitant antagonist given chemotherapy common consequence cancer treatment development anticipatory nausea vomiting kind nausea usually elicited reexposure patients clinical context need attend approximately people undergoing chemotherapy reported develop anticipatory nausea vomiting developed anv difficult control pharmacological means benzodiazepines drugs found reduce occurrence anv efficacy decreases recently clinical trials suggests cannabidiolic acid suppresses conditioned gaping anv anv widely believed learned response best approach avoid development anv adequate prophylaxis treatment acute vomiting nausea first exposure behavioral treatment techniques systematic desensitization progressive muscle relaxation hypnosis shown effective incidence severity radiation therapyinduced nausea vomiting rinv depends number factors including therapy related factors irradiated site single total dose fractionation irradiated volume radiotherapy techniques also involved person related factors gender general health person age concurrent recent chemotherapy alcohol consumption previous experience nausea vomiting anxiety well tumor stage emetogenic potential radiotherapy classified high moderate low minimal risk depending site nausea vomiting may number causes people one cause may exist person stimulating symptoms via one pathway actual cause nausea vomiting may unknown people underlying causes nausea vomiting may cases directly related cancer causes may categorized diseaserelated stimuli lead emesis received processed brain thought number loosely organized neuronal networks within medulla oblongata probably interact coordinate emetic brain stem nuclei identified important coordination emetic reflex include parvicellular reticular formation b√∂tzinger complex nucleus tractus nuclei coordinating emesis formerly referred vomiting complex longer thought represent single anatomical efferent outputs transmit information brain leading motoric response retching vomiting include vagal efferents esophagus stomach intestine well spinal somatomotor neurones abdominal muscles phrenic motor neurones diaphragm autonomic efferents also supply heart airways vagus salivary glands chorda tympani skin responsible many prodromal signs salivation skin nausea vomiting may initiated various stimuli different neuronal pathways stimulus may act one stimuli pathways include strategies management prevention nausea vomiting depend underlying causes whether reversible treatable stage illness persons prognosis person specific factors anti emetic drugs chosen according previous effectiveness side drugs used prophylaxis therapy nausea vomiting cancer include nondrug measures may include palliative care active care people advanced progressive illness cancer world health organization defines approach improves quality life patients families facing problems associated lifethreatening illness prevention relief suffering means early identification impeccable assessment treatment pain problems nausea vomiting physical psychosocial sometimes possible necessary provide relief cancercaused nausea vomiting palliative surgical intervention surgery however routinely carried poor prognostic criteria surgical intervention intraabdominal carcinomatosis poor performance status massive surgical approach proves beneficial affected people operable lesions life expectancy greater months good performance often malignant bowel obstruction cause symptoms case purpose palliative surgery relieve symptoms bowel obstruction means several procedures including million new cancer cases million cancer deaths estimated worldwide httpsenwikipediaorgwikicancerandnausea